Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: What are the direct costs of assisted reproductive technology (ART), and how affordable is it for patients in low- and middle-income countries (LMICS)? SUMMARY ANSWER: Direct medical costs paid by patients for infertility treatment are significantly higher than annual average income and GDP per capita, pointing to unaffordability and the risk of catastrophic expenditure for those in need. WHAT IS KNOWN ALREADY: Infertility treatment is largely inaccessible to many people in LMICs. Our analysis shows that no study in LMICs has previously compared ART medical costs across countries in international dollar terms (US$PPP) or correlated the medical costs with economic indicators, financing mechanisms, and policy regulations. Previous systematic reviews on costs have been limited to high-income countries while those in LMICs have only focussed on descriptive analyses of these costs. STUDY DESIGN, SIZE, DURATION: Guided by the preferred reporting items for systematic reviews and meta-analyses (PRISMA), we searched PubMed, Web of Science, Cumulative Index of Nursing and Allied Health Literature, EconLit, PsycINFO, Latin American & Caribbean Health Sciences Literature, and grey literature for studies published in all languages from LMICs between 2001 and 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: The primary outcome of interest was direct medical costs paid by patients for one ART cycle. To gauge ART affordability, direct medical costs were correlated with the GDP per capita or average income of respective countries. ART regulations and public financing mechanisms were analyzed to provide information on the healthcare contexts in the countries. The quality of included studies was assessed using the Integrated Quality Criteria for Review of Multiple Study designs. MAIN RESULTS AND THE ROLE OF CHANCE: Of the 4062 studies identified, 26 studies from 17 countries met the inclusion criteria. There were wide disparities across countries in the direct medical costs paid by patients for ART ranging from USD2109 to USD18 592. Relative ART costs and GDP per capita showed a negative correlation, with the costs in Africa and South-East Asia being on average up to 200% of the GDP per capita. Lower relative costs in the Americas and the Eastern Mediterranean regions were associated with the presence of ART regulations and government financing mechanisms. LIMITATIONS, REASONS FOR CAUTION: Several included studies were not primarily designed to examine the cost of ART and thus lacked comprehensive details of the costs. However, a sensitivity analysis showed that exclusion of studies with below the minimum quality score did not change the conclusions on the outcome of interest. WIDER IMPLICATIONS OF THE FINDINGS: Governments in LMICs should devise appropriate ART regulatory policies and implement effective mechanisms for public financing of fertility care to improve equity in access. The findings of this review should inform advocacy for ART regulatory frameworks in LMICs and the integration of infertility treatment as an essential service under universal health coverage. STUDY FUNDING/COMPETING INTEREST(S): This work received funding from the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organization (WHO). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: This review is registered with PROSPERO, CRD42020199312.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due to high cost and/or unaffordability, ART remains out of reach for many, even in resource-rich countries (Dyer et al., 2020; ASRM The Ethics Committee, 2021; Njagi et al., 2023).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Njagi et al., 2023
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Systematic reviews have shown that individuals with infertility problems in LMICs are less likely to have access to any form of ART [31,34], even routine medical care, including psychosocial interventions [35].”
The cited source says what the claim attributes to it.
In the citing paper
“Infertility treatment is disproportionately underutilized in LMICs [30,31] due to the high cost of treatment and the limited financial resources of those affected.”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While psychosocial interventions are conceptualized in high-income countries and incorporated in the health systems, LMICs are yet to incorporate them in the management of infertility [31].”
From Psychosocial interventions for improving marital intimacy, sexual satisfaction, and quality of life of women and couples with infertility problems in low and middle-income countries: Systematic review protocol (2025) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“In keeping with the study protocol published in the PROSPERO database (CRD42020199312) and elsewhere (Njagi et al., 2020), this study was conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement (Moher et al., 2009).”
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Boivin, J., Bunting, L., Collins, J. A., & Nygren, K. G. (2007) · Human Reproduction · doi:10.1093/humrep/dem046 · Cited by 2,437 · cited 2×
“While reported prevalence estimates vary widely due to different methodologies, global estimates show that between 48.5 and 72.4 million couples have infertility (Boivin et al., 2007; Mascarenhas et al., 2012).”
InfluentialDevelopment of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)
Downes, M. J., Brennan, M. L., Williams, H. C., & Dean, R. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011458 · Cited by 2,376 · cited 1×
“For cross-sectional studies, we applied the criteria for non-controlled studies complemented by the quality assessment tool for observational and cross-sectional studies provided by the National Institutes of Health (Downes et al., 2016; Ma et al., 2020).”
MethodMascarenhas, M. N., Flaxman, S. R., Boerma, T., Vanderpoel, S., & Stevens, G. A. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001356 · Cited by 2,312 · cited 4×
“However, infertility is itself a widely prevalent cause of significant health burden for millions of people (Makuch et al., 2010; Mascarenhas et al., 2012; Cox et al., 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al.”
BackgroundInfluentialInternational Statistical Classification of Diseases and Related Health Problems 10th Revision
(2013) · A Companion to the Classification of Mental Disorders · doi:10.1093/med/9780199669493.005.0005 · Cited by 2,059
Inhorn, M. C., & Patrizio, P. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv016 · Cited by 1,926 · cited 2×
“intervention throughout the world (Bitler and Schmidt, 2012; Inhorn and Patrizio, 2015; Sharma et al., 2018).”
BackgroundMa, L.-L., Wang, Y.-Y., Yang, Z.-H., Huang, D., Weng, H., & Zeng, X.-T. (2020) · Military Medical Research · doi:10.1186/s40779-020-00238-8 · Cited by 1,648
Starrs, A. M., Ezeh, A. C., Barker, G., Basu, A., Bertrand, J. T., Blum, R., Coll-Seck, A. M., Grover, A., Laski, L., Roa, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30293-9 · Cited by 1,598 · cited 2×
“, 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al., 2018).”
Background
Research works printed but not linked: 9
- International Federation of Fertility Societies’ Surveillance (IFFS), 2019, Global trends in reproductive policy and practice, Glob Reprod Health, 4, e29
- Inhorn, 2012, Infertility and assisted reproduction in the muslim middle east: social, religious, and resource considerations, Facts Views Vis ObGyn, 6, 24
- Khalifa, 2012, Reviewing infertility care in Sudan; socio-cultural, policy and ethical barriers, Facts Views Vis ObGyn, 53
- Sangamithra, 2015, An economic analysis of socio-economic variables and treatment cost of infertility, Shanlax Int J Econ, 3, 5
- Tangwa, 2002, ART and African sociocultural practices: worldview, belief and value systems with particular reference to francophone Africa, Vayena E Curr Pract Controv Assist Reprod, 5, 55
- WHO, 2020, Infertility Fact Sheet
- World Bank, 2021, Low and Middle Income Countries: World Bank Open Data
- World Bank, 2021, PovcalNet
- World Bank, 2021, GDP per capita, PPP (Current International $) International Comparison Program, World Development Indicators Database
Cited by
Fauser, B. C. J. M., Adamson, G. D., Boivin, J., Chambers, G. M., de Geyter, C., Dyer, S., Inhorn, M. C., Schmidt, L., Serour, G. I., Tarlatzis, B., et al. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmad028 · Cited by 224
“Due to high cost and/or unaffordability, ART remains out of reach for many, even in resource-rich countries (Dyer et al. , 2020; ASRM The Ethics Committee, 2021; Njagi et al. , 2023).”
BackgroundSelf-citationEmbryo selection through artificial intelligence versus embryologists: a systematic review
Salih, M., Austin, C., Warty, R. R., Tiktin, C., Rolnik, D. L., Momeni, M., Rezatofighi, H., Reddy, S., Smith, V., Vollenhoven, B. J., et al. (2023) · Human Reproduction Open · doi:10.1093/hropen/hoad031 · Cited by 191
“Annually, the estimated number of couples experiencing infertility worldwide is around 17.5% of the adult population (one in six) (Njagi et al. , 2023).”
InfluentialGaillard, L., Barouki, R., Blanc, É., Coumoul, X., & Andréau, K. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.021 · Cited by 143
Feng, J., Wu, Q., Liang, Y., Liang, Y., & Bin, Q. (2025) · Reproductive Health · doi:10.1186/s12978-025-01966-7 · Cited by 115
“In low-and middle-income countries, the lack of gov-ernment-funded infertility treatments and insurance coverage further limits access, leaving many couples to pay out of pocket, which can lead to significant financial hardship [13].”
Wang, Y., Li, R., Yang, R. J., Zheng, D., Zeng, L., Lian, Y., Zhu, Y., Zhao, J., Liang, X., Li, W., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02416-9 · Cited by 86
Metadata
- Authors
- Njagi, P., Groot, W., Arsenijevic, J., Dyer, S., Mburu, G., & Kiarie, J.
- Affiliations
- United Nations University – Maastricht Economic and Social Research Institute on Innovation and Technology (NL)
- Utrecht University (NL)
- University of Cape Town (ZA)
- World Health Organization (CH)
- Corresponding author
- Njagi, Purity
- Venue
- Human Reproduction Open
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-01-01
- Volume
- 2023
- Issue
- 2
- Pages
- hoad007-hoad007
- ISSN
- 2399-3529 (ISSN-L)
- PMC
- PMC10029849
- OpenAlex
- W4322730891
- Cited by
- 277
- References
- 65
- Citations by year
- 2026: 86 · 2025: 106 · 2024: 71 · 2023: 14
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Human Reproduction Open (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- Funders
- UNDP-UNFPA-UNICEF-WHO-World Bank
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- assisted reproduction, infertility treatment, direct medical costs, patient affordability, low- and middle-income countries, GDP per capita, ART regulation, access to fertility care, health policy implications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review. https://app.cochat.ai/papers/10.1093/hropen/hoad007
- The paper
- Njagi, P., Groot, W., Arsenijevic, J., Dyer, S., Mburu, G., & Kiarie, J. (2023). Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review. Human Reproduction Open. https://doi.org/10.1093/hropen/hoad007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.